NCT00497679View on ClinicalTrials.gov

AZD1152 in Patients With Advanced Solid Malignancies-Study 3

PHASE1TerminatedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

August 31, 2006

Study Completion Date

July 31, 2007

Conditions

Solid Tumours

Interventions

DRUG

AZD1152

7-day continuous intravenous infusion

Trial Locations (3)

Unknown

Research Site, Manchester

Research Site, Newcastle

Research Site, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY